Epigenetic Regulation of Vascular Smooth Muscle Cell Proliferation and Neointima Formation by Histone Deacetylase Inhibition
Author(s) -
Hannes M. Findeisen,
Florence Gizard,
Yue Zhao,
Qing Hua,
Elizabeth B. Heywood,
Karrie L. Jones,
Dianne Cohn,
Dennis Bruemmer
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.221952
Subject(s) - cyclin d1 , histone deacetylase , neointima , histone deacetylase 5 , microbiology and biotechnology , hdac11 , cancer research , biology , cyclin a , vascular smooth muscle , retinoblastoma protein , cell growth , hdac4 , histone deacetylase 2 , trichostatin a , cell cycle , histone , cell , biochemistry , medicine , endocrinology , gene , restenosis , smooth muscle , stent
Proliferation of smooth muscle cells (SMC) in response to vascular injury is central to neointimal vascular remodeling. There is accumulating evidence that histone acetylation constitutes a major epigenetic modification for the transcriptional control of proliferative gene expression; however, the physiological role of histone acetylation for proliferative vascular disease remains elusive.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom